CLBT Stock Summary and Trading Ideas (Cellebrite Di Ltd. - | NASDAQ:CLBT)

Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.

Cellebrite Di Ltd. - trades on the NASDAQ stock market under the symbol CLBT.

As of February 2, 2026, CLBT stock price climbed to $14.90 with 1,656,180 million shares trading.

CLBT has a beta of 0.54, meaning it tends to be less sensitive to market movements. CLBT has a correlation of 0.04 to the broad based SPY ETF.

CLBT has a market cap of $3.57 billion. This is considered a Mid Cap stock.

Last quarter Cellebrite Di Ltd. - reported $126 million in Revenue and $.14 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.02.

In the last 3 years, CLBT traded as high as $26.30 and as low as $4.87.

The top ETF exchange traded funds that CLBT belongs to (by Net Assets): IEFA, SCZ, TMFG, WCLD, IXUS.

CLBT has underperformed the market in the last year with a price return of -37.9% while the SPY ETF gained +16.1%. CLBT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -13.2% and -12.4%, respectively, while the SPY returned +2.6% and +0.5%, respectively.

CLBT support price is $14.34 and resistance is $15.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLBT shares will trade within this expected range on the day.